Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6910
+0.0122 (1.80%)
At close: May 21, 2025, 4:00 PM
0.7249
+0.0339 (4.91%)
After-hours: May 21, 2025, 7:52 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $61.99 million as of May 21, 2025. Its market cap has increased by 109.86% in one year.
Market Cap
61.99M
Enterprise Value
-27.17M
1-Year Change
109.86%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $61.99M, an increase of 21.47%. That is a compound annual growth rate of 5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 60.89M | -35.35% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.21B |
| Johnson & Johnson | 369.04B |
| AbbVie | 325.27B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.92B |
| Abbott Laboratories | 235.26B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |